Technology News and Research

RSS

Avalon Healthcare Solutions receives additional investment from Francisco Partners

Avalon Healthcare Solutions today announced a second round of investment from Francisco Partners. The incremental capital will be used to enhance Avalon's comprehensive laboratory management technology and clinical capabilities, as well as to strengthen growth opportunities.

7 Jan 2016

Experts develop technologies for protecting drinking water

We place high demands on the quality of our drinking water. If pathogens or toxic substances found their way into the piping system, many people could become infected or injured very quickly. That's why this risk must be kept low. To do this, experts have developed technologies for a comprehensive monitoring, early warning and emergency management system.

7 Jan 2016

Interpretation of images starts in the retina

Tübingen researchers have shown that image processing in the eye is more extensive than previously thought. They investigated the channels that transmit information from the eye to the brain.

7 Jan 2016

New injectable agent can potentially increase surgeon's ability to remove cancerous tumor during surgery

Doctors at the Duke University School of Medicine have tested a new injectable agent that causes cancer cells in a tumor to fluoresce, potentially increasing a surgeon's ability to locate and remove all of a cancerous tumor on the first attempt. The imaging technology was developed through collaboration with scientists at Duke, the Massachusetts Institute of Technology and Lumicell Inc.

7 Jan 2016

Stevens Institute of Technology professor receives $50,000 grant to advance research into thoracic catheter

Vikki Hazelwood, PhD, a professor in the Department of Biomedical Engineering, Chemistry and Biological Sciences at Stevens Institute of Technology, has received a $50,000 Innovation Grant from New Jersey Health Foundation/The Nicholson Foundation to advance research into a catheter that may prevent frequent complications for patients following a variety of surgical procedures, announced James M. Golubieski, president of New Jersey Health Foundation.

7 Jan 2016

UD professor explores impact of STEGH programs on medical students

As American medical students increasingly want and expect to have international work experience, more and more short-term programs are being offered to give them that opportunity, according to Melissa Melby, assistant professor of anthropology at the University of Delaware.

7 Jan 2016

New CRISPR technology can be used to make designer babies

How should we handle the new CRISPR technology that can both advance science and medicine, but also be used to make designer babies? Scientist and author Paul Knoepfler tackles this and other difficult questions related to this revolutionary technology in his new book, GMO Sapiens: The Life-Changing Science of Designer Babies, targeted at a broad, lay audience.

7 Jan 2016

Scientists seek development of advanced tools to explore microbiomes

In October, an interdisciplinary group of scientists proposed forming a Unified Microbiome Initiative (UMI) to explore the world of microorganisms that are central to life on Earth and yet largely remain a mystery. An article in the journal ACS Nano describes the tools scientists will need to understand how microbes interact with each other and with us.

7 Jan 2016

JJHWS, Plug and Play Tech Center partner to support companies developing wellness solutions

Johnson & Johnson Health and Wellness Solutions, Inc. today announced a collaboration with Plug and Play Tech Center, a global investor and technology accelerator, to support innovative, early-stage companies developing direct-to-consumer solutions that enhance wellness.

7 Jan 2016

MGC Diagnostics' total revenues grow 24.9% to $37.5 million in fiscal year 2015

MGC Diagnostics Corporation, a global medical technology company, today reported financial results for the fourth quarter and the fiscal year 2015, ended October 31, 2015.

6 Jan 2016

Rani Therapeutics, MedImmune collaborate to evaluate novel oral drug delivery platform

Rani Therapeutics announced today that it has entered into a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, to evaluate Rani's novel oral drug delivery platform. The companies have agreed to conduct feasibility studies over the next two years, in which Rani will test select biologic molecules in the area of metabolic disease to evaluate the oral delivery of these molecules.

6 Jan 2016

Patient access to online GP records: an interview with Bob Zemke

It's very much in line with what we're seeing globally with national and even private practice initiatives – providing more patient engagement and enabling patients to see their own records.

6 Jan 2016

Scientists successfully create fully-functional pancreatic cells from human skin cells

Scientists at the Gladstone Institutes and the University of California, San Francisco have successfully converted human skin cells into fully-functional pancreatic cells. The new cells produced insulin in response to changes in glucose levels, and, when transplanted into mice, the cells protected the animals from developing diabetes in a mouse model of the disease.

6 Jan 2016

MU researchers to present new disaster management system at 2016 Consumer Electronics Show

Two University of Missouri researchers will present Panacea's Cloud, a new disaster management system, at the 2016 Consumer Electronics Show on Jan. 6-9, 2016, in Las Vegas.

6 Jan 2016

Global action on reducing mercury emissions should lead to billions in economic benefits for U.S.

Mercury pollution is a global problem with local consequences: Emissions from coal-fired power plants and other sources travel around the world through the atmosphere, eventually settling in oceans and waterways, where the pollutant gradually accumulates in fish. Consumption of mercury-contaminated seafood leads to increased risk for cardiovascular disease and cognitive impairments.

6 Jan 2016

Vision of Britain report shows more than 3 in 10 GPs ‘de-skilled’ in diagnosing eye conditions

New research released today reveals an alarming, self-acknowledged gap in family doctors’ skills when it comes to diagnosing and treating patient’s eye conditions.

6 Jan 2016

Millendo signs license agreement, secures funding to test new drugs for treatment of endocrine disorders

Millendo Therapeutics, a University of Michigan startup company, announced an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to test a new compound, MLE4901, for the treatment of polycystic ovary syndrome.

6 Jan 2016

Technology News and Research

Avalon Healthcare Solutions receives additional investment from Francisco Partners

Experts develop technologies for protecting drinking water

Interpretation of images starts in the retina

New injectable agent can potentially increase surgeon's ability to remove cancerous tumor during surgery

Stevens Institute of Technology professor receives $50,000 grant to advance research into thoracic catheter

UD professor explores impact of STEGH programs on medical students

New CRISPR technology can be used to make designer babies

Scientists seek development of advanced tools to explore microbiomes

JJHWS, Plug and Play Tech Center partner to support companies developing wellness solutions

MGC Diagnostics' total revenues grow 24.9% to $37.5 million in fiscal year 2015

Rani Therapeutics, MedImmune collaborate to evaluate novel oral drug delivery platform

Patient access to online GP records: an interview with Bob Zemke

Scientists successfully create fully-functional pancreatic cells from human skin cells

MU researchers to present new disaster management system at 2016 Consumer Electronics Show

Global action on reducing mercury emissions should lead to billions in economic benefits for U.S.

Vision of Britain report shows more than 3 in 10 GPs ‘de-skilled’ in diagnosing eye conditions

Millendo signs license agreement, secures funding to test new drugs for treatment of endocrine disorders

Sentrian selected as a 2015 Global Digital Health 100 company

Epigenetics in Drug Discovery

Pathway Genomics secures over $40 million in Series E financing

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News